Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...
Gilead's Sovaldi (sofosbuvir) was launched in the US in December, and is already transforming the treatment of Hepatitis C, thanks to its ability to cure far more patients than existing treatments ...
Furthermore, fever over 38°C within 24 h of initial ICI treatment was also identified as another risk factor for IMH (HR ... Anti-CTLA-4 drugs are mainly characterized by specific patterns of ...
The results showed chronic hepatitis with inflammation staging “G2” and fibrosis staging “S3.” Both the blood cell count and ALT levels were in the normal range, and the level of HBV DNA was 37,900 IU ...